Aug 2026· Expert review of pharmacoeconomics & outcomes research· pp.
1-10
· 0 citations· 27 references
Medicine
TL;DR
This review examines current applications of LLMs to health economic modeling in terms of reproducibility, validation, adaptability, and technology readiness and concludes that near-term gains are augmenting human modelers on decomposed, verifiable sub-tasks rather than pursuing autonomous end-to-end modeling.
Abstract
INTRODUCTION
Health economic models (HEMs) provide a solid foundation for reimbursement policy decisions that shape patient access to new treatments and the allocation of scarce healthcare resources. Model development is labor-intensive and time-consuming, often requiring months of expert work. Recent advances in large language models (LLMs) prompted interest in whether artificial intelligence can support or partially automate this process, but the evidence base remains scattered and has not been mapped against the modeling workflow.
AREAS COVERED
This review examines current applications of LLMs to health economic modeling. Five proof-of-concept studies are included and mapped to an eight-stage workflow adapted from the ISPOR-SMDM Modeling Good Research Practices framework and discussed in terms of reproducibility, validation, adaptability, and technology readiness. Published work addressed model parameterization, model implementation, reporting and quality assessment, and local adaptation, while research question design, model conceptualization, uncertainty analysis, and model validation remained unaddressed.
EXPERT COMMENTARY
The evidence supports cautious optimism. Near-term gains are augmenting human modelers on decomposed, verifiable sub-tasks rather than pursuing autonomous end-to-end modeling, which remains distant given current reliability levels and the iterative, collaborative nature of model development.
Although promising, LLM-based systems are not yet reliable enough for autonomous medical diagnosis, and multiple recommendations for future research are contained to ensure a high level of safety, transparency, and clinical applicability for LLMs and other AI/ML-related technologies and devices.
M. U. K. Gunawardhna, Pirunthavi Wijikumar, D. Weerasinghe· Sri Lankan Journal of Applie...· 1 citation
This systematic review provides a comprehensive analysis of XAI methods specifically applied to tabular healthcare data for classification tasks, revealing that SHAP remains the dominant post-hoc method, achieving strong model fidelity but showing inconsistent alignment with clinical expert reasoning.
Angelower Santana-Velásquez, M. B. Salazar-Sánchez· Computers· 0 citations
Findings support a hybrid paradigm in which AI augments, but does not replace, health economists in value assessment and formulary decision support within managed care settings.
R. Mudumba, A. Modi, Kevin Mayo· Journal of Managed Care & Sp...· 0 citations
A practical, hands-on guide for non-coders to build basic ML models using structured health data using four user-friendly, no-code applications developed using R and Shiny, which empowers clinicians, including radiologists, to transform routine clinical data into actionable predictive tools.
Himel Mondal, Pradosh Kumar Sarangi, Shaikat Mondal· Indian Journal of Radiology...· 0 citations
This entry-level tutorial aims to equip healthcare professionals with the tools necessary to effectively integrate LLMs into clinical practice, ensuring that these powerful technologies are applied in a safe, reliable, and impactful manner.
Qiao Jin, Nicholas Wan, Robert Leaman et al.· Nature Protocols· 1 citation
Deploying artificial intelligence systems for medical image analysis in clinical settings involves considerations that go beyond model accuracy: infrastructure constraints, integration with existing workflows, and generalization across patient populations all determine whether a system works outside a research lab. Thi...
Humberto J. Navarro, M. S. González, Nubia Y. Piñeros et al.· Journal of Intelligent Decis...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.